DIST_0104_pnas.2016034118

SLC12A5, Rho kinase as targets for mutation-associated intellectual disability

Jan 30, 2021 | 1:16 AM GMT

DISEASE CATEGORY: Neurology

INDICATION: Cognitive dysfunction

Inhibiting SLC12A5, a cation-Cl cotransporter, or Rho kinase could

Read the full 242 word article

How to gain access

Continue reading with a
two-week free trial.